Topics

Companies Related to "First experimental genetic evidence human self domestication hypothesis" [Most Relevant Company Matches] RSS

00:33 EST 20th February 2020 | BioPortfolio

Here are the most relevant search results for "First experimental genetic evidence human self domestication hypothesis" found in our extensive corporate database of over 50,000 company records.

Showing "First experimental genetic evidence human self domestication hypothesis" Companies 1–25 of 2,600+

Relevant

CENTOGENE

CENTOGENE unlocks the power of genetic insights to improve the quality of life of patients with rare genetic diseases. We achieve this through knowledge created by our worldwide diagnostic testing services incorporating global diversity, the world’s leading proprietary human genetic interpretation database, CentoMD® and solutions for pharmaceutical...


Population Genetics

Harnessing The Power of Populations™ Population Genetics’ approach takes the process of genetic analysis one step further. It enables the elaboration and testing of distinct hypotheses focused on both contiguous and non-contiguous regions of the genome. Whether these have been identified by other technologies such as investigation of gene expression levels, copy number variation, p...

Genetic Analysis

Genetic Analysis has developed and launched the first gene-based routine test for the mapping and diagnosis of diseases related to dysbiosis and imbalances in the bacteria in the digestive system. The company markets the GA-map™ technology to three market segments: commercial routine testing, pharma companies and the research market. Genetic Analysis ...


Multiplicom N.V.

Multiplicom produces molecular diagnostic kits that enable clinical laboratories to perform affordable testing for personalized medicine. The company was created in 2011 as a spin-off by the University of Antwerp and VIB. Multiplicom develops, manufactures and commercializes leading-edge and easy-to-use genetic test kits based on the latest molecular diagnostic technologies. The successful intro...

Society for Experimental Biology

The Society for Experimental Biology promotes and supports all disciplines of Experimental Biology worldwide. All researchers, teachers and students who have an interest in any aspect of experimental biology are encouraged to join.SEB membership is open to scientists world-wide.The Society provides:Timely and topical meetings across the interests of the Society. A forum for experimental biologists...

Recursion Pharmaceuticals, LLC

Recursion is a clinical-stage biotechnology company combining experimental biology and automation with artificial intelligence methods in a massively parallel system to efficiently discover potential drugs for diverse indications, including genetic disease, inflammation, immunology, and infectious disease. Recursion applies causative perturbations to human...

Color Genomics

Color Genomics provides a high-quality, physician-ordered, genetic test for 19 genes related to breast and ovarian cancer risk, including BRCA1 and BRCA2. The Color Test includes support for physicians, as well as genetic counseling as part of every order. Color’s goal is to expand physician-supported access to genetic information for breast and ovarian ...

Genetic Technologies Limited

Genetic Technologies was an early pioneer in recognizing important new applications for “non-coding” DNA (Deoxyribonucleic Acid). The Company has since been granted patents in 24 countries around the world, securing intellectual property rights for particular uses of non-coding DNA in genetic analysis and gene mapping across all genes in all spec...

Doctor Evidence, LLC

Doctor Evidence is the leader in the development of digital software technologies and services that find/store/translate and deliver the evidence, from clinical studies, to Life Science, Healthcare, Academic and Government organizations. The DRE database software enable the user to conduct meta and other analyses with the highest level of accuracy, ...

Knome, Inc.

Knome is a commercial stage life sciences company that specializes in the interpretation of human genomes. Knome supports researchers with the informatics and software tools they need to investigate the genetic basis of human disease and drug response. In addition, the company provides researchers, drug developers and clinics with end-to-end genome interpr...

Natera, Inc.

Natera is a genetic testing company that has developed a proprietary bioinformatics technology (Parental Support) to deliver accurate and comprehensive high throughput testing for reproductive indications from tiny quantities of DNA – as small as that from a single cell. Natera operates a CLIA laboratory in Redwood City, Calif., providing a host of pr...

Interleukin Genetics, Inc.

Interleukin Genetics, Inc. (OTCQB: ILIU) develops and markets a line of genetic tests under the Inherent Health® brand. The products empower individuals to prevent certain chronic conditions and manage their existing health and wellness through genetic-based insights with actionable guidance. Interleukin Genetics leverages its research, intell...

INCAM

INCAM has institute structure, two experimental stations located in the field. From its direct interaction with the medium, the benefit for producers, technicians, professionals and companies will arise. The services of the consultant cabinets of INCAM include practically all problems the production sector has to face. INCAM S.A. provides with complete services to the pharmaceutical, veterinary, a...

Electrical Injury

Electrical accident reconstruction. Expert in electrical accident causation and associated human response. Analysis of the human-machine interface. Extensive federal and state testimony experience. Publication on electrical injury. Accident reconstruction based on burn injury pattern and other physical evidence. Analysis of pain and suffering. Human factors associated with electrical contact. ...

Ambry Genetics Corporation

Ambry Genetics is a privately held healthcare company with the industry’s most comprehensive suite of genetic testing solutions, benefiting 90% of all U.S. patients covered by public and private insurers. Ambry Genetics is dedicated to scientific collaboration and the belief that human health should not be patented or owned.

ScienCell Research Laboratories

ScienCell Research Laboratories (ScienCell) is a biotechnology company whose mission is the research and development of cell and cell-related products for experimental and therapeutic use. The ScienCell technology provides a variety of high quality normal human and animal cells, cell culture media and reagents, medium supplements, cell-derived RNA, cDNA and proteins for the research community. Sci...

Azitra Inc.

Azitra, Inc. is a clinical-stage medical dermatology company that combines the power of the microbiome with cutting-edge genetic engineering to treat skin disease. The company was founded in 2014 by scientists from Yale University and works with world-leading scientists in dermatology, microbiology, and genetic engineering to advance its pharmaceutical programs to treat cancer therapy associated ...

2bPrecise

The cloud-based 2bPrecise platform consumes genomic/genetic data (from any molecular lab) and clinical information (from any EHR), combining them into a comprehensive patient record. The solution applies insights from multiple curated, evidence-based knowledgebases and then injects the data back into the provider’s native workflow. The 2bPrecise platf...

United BioSource Corporation

Market forces and public opinion have intensified the need for pharmaceutical and life sciences companies to deliver credible evidence supporting the use of their products. UBC has pioneered a new company specializing in evidence-based product support to meet this burden of proof. We understand the critical importance of evidence and this understanding informs our mission: to be the leading provid...

Genea Stem Cells Pty Ltd

Genea Biocells Pty Ltd is a subsidiary of Genea Limited (formerly Sydney IVF Limited), a public, unlisted company that has been operating IVF clinics in Australia since 1985. Genea Biocells Pty Ltd is governed by the same strong ethical principles and corporate governance practices. Genea Biocells is located in Sydney, Australia and has been supplying commercial stem cell solutions for several...

Xenon Pharmaceuticals Inc

Xenon is a privately held company located in Vancouver and has just over 70 employees. We are a leader in clinical genetic based drug discovery and development and have built a worldwide network of over 40 clinical collaborators to find and access the rare families with diseases of relevance to drug discovery. Our clinical genetic approaches are: Extreme Genetics TM: the analysis of rare families ...

Amicus Therapeutics

Amicus Therapeutics is pioneering a paradigm-shifting approach to treating a range of human genetic diseases in which crucial proteins are misfolded, thus reducing or eliminating their functionality. Amicus develops pharmacological chaperones - oral therapies that bind to and stabilize the affected proteins, restoring their shape, proper trafficking, and biological activity. This novel, next-gener...

Anji Pharmaceuticals, Inc.

With its platform of using human genetic data to drive target selection, Anji has built a robust pipeline of clinical assets to treat cardiometabolic disorders. Anji has recruited a nimble and experienced clinical team to advance novel treatment paradigms, especially in the areas of gut and lipid metabolism. Anji’s pipeline reflects their strategy to ...

CompanionDx

With locations in Houston, Texas and Honolulu, Hawaii, CompanionDx™ Reference Lab is a high-complexity CLIA certified laboratory specializing in pharmacogenomics, cancer companion diagnostics, targeted NGS and epigenomics testing. CompanionDx™ is committed to the next evolution in cancer care where comprehensive genetic data is delivered in an ac...

Article One Partners, LLC

Article One Partners, LLC is the only patent validity company to employ an online community of more than 3 million people, networked across the globe to uncover previously undisclosed patent quality evidence. Article One's community of researchers forms a unique pool of domain experts who submit new invalidity evidence and for between $10,000 to $50,000 per research project and share in the compan...


More From BioPortfolio on "First experimental genetic evidence human self domestication hypothesis"

Quick Search

Corporate Database Quicklinks